Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy
暂无分享,去创建一个
M. Ohmichi | Tomohito Tanaka | H. Sasaki | Y. Terai | H. Azuma | N. Ibuki | T. Ubai | Kazuhiro Yamamoto | S. Fujiwara | Yoshimichi Tanaka | Satoshi Tsunetoh | Masaaki Takai
[1] M. Ohmichi,et al. Neoadjuvant intra-arterial chemotherapy using an original four-lumen double-balloon catheter for locally advanced uterine cervical cancer , 2018, Oncotarget.
[2] M. Thakur,et al. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Takeda,et al. Outcome of Neoadjuvant Intra-Arterial Chemotherapy and Radical Hysterectomy for Treatment of Bulky Stage IB to Stage IIB Uterine Cervical Cancer: Can Postoperative Irradiation Be Avoided? , 2016, International Journal of Gynecologic Cancer.
[4] S. Park,et al. Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial , 2015, Journal of gynecologic oncology.
[5] L. Dušek,et al. Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review , 2015, Annals of Surgical Oncology.
[6] R. Velthoven,et al. Lower urinary tract dysfunction after nerve-sparing radical hysterectomy , 2015, International Urogynecology Journal.
[7] J. Lang,et al. Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial? , 2014, OncoTargets and therapy.
[8] Ying Long,et al. Clinical Efficacy and Safety of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.
[9] M. Ohmichi,et al. Role of the two-point pull-up technique for treating the uterine arteries during radical hysterectomy and trachelectomy. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[10] Kaoru Kobayashi,et al. Prognostic Factors for Locally Advanced Cervical Cancer Treated With Neoadjuvant Intravenous and Transuterine Arterial Chemotherapy Followed by Radical Hysterectomy , 2013, International Journal of Gynecologic Cancer.
[11] F. Akiyama,et al. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy. , 2010, Gynecologic oncology.
[12] M. Kaneuchi,et al. Risk Factors for Persistent Low Bladder Compliance After Radical Hysterectomy , 2010, International Journal of Gynecologic Cancer.
[13] T. Sugiyama,et al. Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancer. , 2010, Oncology letters.
[14] I. Narabayashi,et al. Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer , 2009, International Journal of Clinical Oncology.
[15] N. Matsumura,et al. Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy. , 2007, Gynecologic oncology.
[16] P. Maisonneuve,et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[17] A. Peters,et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients , 2002, International Journal of Gynecologic Cancer.
[18] A. Schneider,et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. , 2000, Gynecologic oncology.
[19] Koyo Yoshida,et al. New Method to Prevent Bladder Dysfunction after Radical Hysterectomy for Uterine Cervical Cancer , 2000, The journal of obstetrics and gynaecology research.
[20] S. Hsueh,et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. , 1997, Gynecologic oncology.
[21] F. Parazzini,et al. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer. , 1996, Gynecologic oncology.
[22] H. Nishimoto,et al. A new proposal for radical hysterectomy. , 1996, Gynecologic oncology.
[23] F. Debruyne,et al. Radical Hysterectomy And The Function Of The Lower Urinary Tract: Urodynamic Quantification Of Changes In Storage And Evacuation Function , 1989, Acta obstetricia et gynecologica Scandinavica.
[24] D. Wallwiener,et al. Detrusor and compliance changes of the bladder after radical hysterectomy. , 1989, European journal of gynaecological oncology.
[25] W. Lichtenegger,et al. Urological complications after radical abdominal hysterectomy for cervical cancer. , 1988, Bailliere's clinical obstetrics and gynaecology.
[26] J. Huang,et al. Prospective urodynamic study before and after radical hysterectomy. , 1988, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.
[27] N. Kadar,et al. The frequency, causes and prevention of severe urinary dysfunction after radical hysterectomy , 1983, British journal of obstetrics and gynaecology.
[28] J. Forney. The effect of radical hysterectomy on bladder physiology. , 1980, American journal of obstetrics and gynecology.
[29] R. Gori. [Carcinoma of the cervix uteri]. , 1970, Prensa medica argentina.